Huang Hui | Cardiovascular Disease | Best Researcher Award

Posted on by PencisLeave a Comment on Huang Hui | Cardiovascular Disease | Best Researcher Award

Prof Huang Hui | Cardiovascular Disease | Best Researcher Award

The Eighth Affiliated Hospital of Sun Yat-Sen University | China

Author Profile

Orcid ID

🌟 Biography of Huang Hui: A Trailblazer in Cardiology and Chronic Disease Management 🌟

EARLY ACADEMIC PURSUITS 🎓

Huang Hui’s academic journey is marked by exceptional dedication and excellence. After earning his medical degree, he pursued advanced training at the Medical College of Georgia, USA. This formative experience allowed him to delve deeply into clinical and research methodologies, setting the foundation for his future work in hypertension, cardio-renal syndrome, and pregnancy-induced hypertension.

PROFESSIONAL ENDEAVORS 🚑

Huang Hui serves as:

  • Second-grade professor
  • Chief physician
  • Vice President of the Eighth Affiliated Hospital of Sun Yat-sen University
  • Secretary of the Party Branch of the Department of Cardiology

He is also a visionary leader, directing multiple key research initiatives:

  1. Guangdong-Hong Kong-Macao University Joint Laboratory of Nutrition Metabolism and Precise Prevention and Control of Major Chronic Diseases
  2. Shenzhen Key Laboratory of Precise Prevention and Control and Metabolism of Major Chronic Diseases

Huang Hui has earned recognition as an Outstanding Young Medical Talent of Guangdong Province, underscoring his commitment to advancing medicine in the region.

CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASE🔬

Huang Hui’s research primarily revolves around:

  • Hypertension
  • Cardio-renal syndrome
  • Pregnancy-induced hypertension

His groundbreaking work has been funded through prestigious grants, including:

  • National Natural Science Foundation (Key, National Cooperation, Major Research Program, and Excellent Youth Projects)

IMPACT AND INFLUENCE 🌍

Huang Hui’s influence in the field of cardiology is profound. His research has not only advanced medical understanding but also transformed clinical practice. He is a guiding force in multiple organizations:

  • Vice Chairman, Hypertension Branch of the China Geriatric Health Care Association
  • Chairman, Cardiovascular Health Professional Committee of Guangdong Clinical Medicine Society
  • Chairman, Arrhythmia Professional Committee of Guangdong Association of Integrated Chinese and Western Medicine
  • Chairman, Hypertension Branch of Guangdong Precision Medicine Application Society

ACADEMIC CITES 📚

In the past five years, Huang Hui has published extensively in leading journals. As a corresponding author, his works have appeared in:

  • Circulation (2022, 2023)
  • J Clin Invest. (2021, 2022)
  • Hypertension (2018, 2021, 2022)
  • STTT (2022, 2023, 2024)
  • Kidney Int. (2024)
  • Cardiovasc Res. (2023)

Many of these papers are:

  • ESI Highly Cited Papers
  • TOP100 High-Value Papers
  • Top Ten Research Papers in Chinese cardiovascular diseases
  • Featured as Cover Stories

LEGACY AND FUTURE CONTRIBUTIONS 🏅

Huang Hui’s contributions have shaped the landscape of cardiology and chronic disease management. His pioneering research continues to set benchmarks, particularly in precision prevention and metabolic studies. Looking ahead, Huang Hui is poised to:

  • Drive innovations in precision medicine.
  • Train the next generation of clinicians and researchers.
  • Expand interdisciplinary collaborations between traditional Chinese medicine and modern cardiology.

CLOSING REMARKS 🌟

Huang Hui embodies the essence of a modern physician-scientist. Through his clinical acumen, research expertise, and leadership, he continues to make strides in transforming global health. His work stands as an inspiration for the medical community and beyond.

NOTABLE PUBLICATIONS 📑

"Digital therapeutics in hypertension: How to make sustainable lifestyle changes" 

  • Authors: Chaoyi Chen; Aiting Liu; Zhengzhipeng Zhang; Jie Chen; Hui Huang
  • Journal: The Journal of Clinical Hypertension
  • Year: 2024

"Sex difference in human diseases: mechanistic insights and clinical implications" 

  • Authors: Yuncong Shi; Jianshuai Ma; Sijin Li; Chao Liu; Yuning Liu; Jie Chen; Ningning Liu; Shiming Liu; Hui Huang
  • Journal: Signal Transduction and Targeted Therapy
  • Year: 2024

"Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials" 

  • Authors: Yuncong Shi; Huanji Zhang; Suli Huang; Li Yin; Feng Wang; Pei Luo; Hui Huang
  • Journal: Signal Transduction and Targeted Therapy
  • Year: 2022

"Indoleamine 2,3-Dioxygenase 1 Deletion–Mediated Kynurenine Insufficiency in Vascular Smooth Muscle Cells Exacerbates Arterial Calcification" 

  • Authors: Liu Ouyang; Changjiang Yu; Zhiyong Xie; Xiaoyan Su; Zengmei Xu; Ping Song; Jian Li; Hui Huang; Ye Ding; Ming-Hui Zou
  • Journal: Circulation
  • Year: 2022

" Capsaicin Attenuates Arterial Calcification Through Promoting SIRT6-Mediated Deacetylation and Degradation of Hif1α (Hypoxic-Inducible Factor-1 Alpha)" 

  • Authors: Dongling Luo; Wenxin Li; Changming Xie; Li Yin; Xiaoyan Su; Jie Chen; Hui Huang
  • Journal: Hypertension
  • Year: 2022

Youxin Wang | Epidemiology | Best Researcher Award 

Posted on by PencisLeave a Comment on Youxin Wang | Epidemiology | Best Researcher Award 

Prof Youxin Wang | Epidemiology | Best Researcher Award 

North China University of Science and Technology | China

Author Profile

Scopus

Orcid ID

📚 YOUXIN WANG: A TRAILBLAZER IN PUBLIC HEALTH AND EPIDEMIOLOGY

EARLY ACADEMIC PURSUITS 🎓

Youxin Wang began her distinguished academic journey at the University of the Chinese Academy of Sciences, where she pursued a Ph.D. in Chemistry and Molecular Biology from 2005 to 2008. Her foundational training in this highly interdisciplinary field laid the groundwork for her future endeavors in public health, epidemiology, and health statistics. This early academic excellence positioned her as a versatile researcher capable of bridging molecular sciences with public health concerns.

PROFESSIONAL ENDEAVORS 👩‍🏫

Youxin Wang has held several prestigious positions, marking her steady ascent through academia:

  • Professor at the North China University of Science and Technology (2023 - Present): Currently, she holds the position of Professor at the School of Public Health, where she continues to expand her research and influence.
  • Professor at Capital Medical University (2019 - 2022): At the Department of Epidemiology and Health Statistics, she contributed to key public health initiatives and academic research.
  • Associate Professor at Capital Medical University (2014 - 2018): During this time, Wang honed her skills in teaching and mentoring the next generation of health professionals.
  • Lecturer at Capital Medical University (2008 - 2013): Her initial role at the same institution, where she laid the foundation of her teaching and research career.

CONTRIBUTIONS AND RESEARCH FOCUS ON EPIDEMIOLOGY🔬

Youxin Wang's research has focused on epidemiology, particularly in the fields of health statistics and the intersection of molecular biology and public health. She received funding from the National Natural Science Foundation of China for her groundbreaking project, Significance of Plasma N-glycome in Predicting Type 2 Diabetes and the Glycome-Genome Association Study (2014 - 2017). This research aimed to better understand the genomic predictors of diabetes, offering valuable insights for early diagnosis and treatment.

IMPACT AND INFLUENCE 🌍

Throughout her career, Youxin Wang has contributed to significant developments in public health, particularly in epidemiological methods and the study of chronic diseases like diabetes. Her role as an Adjunct Professor at Edith Cowan University (2020 - Present) reflects her international influence and collaborative efforts in advancing global health research. She has mentored students and professionals, shaping the future of public health research.

ACADEMIC CITES AND RECOGNITION 🏆

With a robust publication record and numerous citations, Youxin Wang’s work has been recognized both in China and internationally. Her innovative research on the plasma N-glycome and its role in diabetes prediction has garnered significant attention in epidemiological and biochemical research circles.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

Youxin Wang's lasting legacy lies in her integrative approach to public health, combining molecular biology with epidemiology to address real-world health issues. As she continues her professorship at North China University of Science and Technology, she is poised to make further advancements in public health, with a focus on chronic disease prediction and prevention. Her ongoing research and mentorship will undoubtedly continue to influence both the scientific community and healthcare systems worldwide.

NOTABLE PUBLICATIONS 📑

"Associations of metabolic changes and polygenic risk scores with cardiovascular outcomes and all-cause mortality across BMI categories: a prospective cohort study" 

  • Authors: Li, C. , Meng, X. , Zhang, J. , Sun, S. , Wang, Y.
  • Journal: Cardiovascular Diabetology
  • Year: 2024

"Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations" 

  • Authors: Liu, D. , Cao, M. , Wang, H. , Li, Y. , Wang, Y.
  • Journal: BMC Medicine
  • Year: 2024

"Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study)" 

  • Authors: Zhang, P.-P. , Wang, Y.-X. , Shen, F.-J. , Wang, H. , Li, L.
  • Journal: Trials
  • Year: 2024

"Potentially causal association between immunoglobulin G N-glycans and cardiometabolic diseases: Bidirectional two-sample Mendelian randomization study" 

  • Authors: Meng, X. , Liu, D. , Cao, M. , Wang, W. , Wang, Y.
  • Journal: International Journal of Biological Macromolecules
  • Year: 2024

"Establish a noninvasive model to screen metabolic dysfunction-associated steatotic liver disease in children aged 6–14 years in China and its applications in high-obesity-risk countries and regions" 

  • Authors: Liu, Y. , Wang, Y. , Xing, Y. , Wang, H. , Song, Y.
  • Journal: The Lancet Regional Health - Western Pacific
  • Year: 2024